Cargando…

Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization

Expression of epidermal growth factor receptor (EGFR) has been associated with radioresistance in cancer. Moreover, tumour cell recovery after irradiation paradoxically occurs, in part, as a result of activation of EGFR signalling by such treatment. A recent article by Huang, Li, Armstrong and Harar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gee, Julia MW, Nicholson, Robert I
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165000/ https://www.ncbi.nlm.nih.gov/pubmed/12793892

Ejemplares similares

Radiosensitization of head and neck cancer by targeting the epidermal growth factor receptor
por: Goel, Arun Kumar, et al.
Publicado: (2009)

Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
por: Gee, Julia MW, et al.
Publicado: (2004)

The temperature and pH repertoire of the transglutaminase family is expanding
por: Lerner, Aaron, et al.
Publicado: (2020)

Epidermal growth factor receptor signaling and the progression of diabetic nephropathy
por: Koya, Daisuke
Publicado: (2015)

Expanding CRISPR repertoire using CjCas9 as a smaller editing tool
por: Francis, Christopher, et al.
Publicado: (2022)

Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
por: Sobani, Zain A, et al.
Publicado: (2016)

Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?
por: Musgrove, Elizabeth A
Publicado: (2004)

Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations
por: Miyauchi, Eisaku, et al.
Publicado: (2019)

Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells
por: Yu, Tosol, et al.
Publicado: (2016)

Epidermal Growth Factor Receptors and Breast Cancer
por: Farndon, J. R., et al.
Publicado: (1989)

Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells
por: Li, Ping, et al.
Publicado: (2013)

Commentary: Guideline for Performing Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Quantitative Image Analysis well
por: Beckwith, Bruce
Publicado: (2019)

Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells
por: van Rossum, Agnes GSH, et al.
Publicado: (2005)

Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer.
por: Sharma, A. K., et al.
Publicado: (1994)

Silencing human epidermal growth factor receptor‐3 radiosensitizes human luminal A breast cancer cells
por: He, Guofeng, et al.
Publicado: (2018)

Prospects for the future of epidermal growth factor receptor-tyrosine kinase inhibitors in combination with bevacizumab
por: Chikaishi, Yasuhiro, et al.
Publicado: (2020)

Epidermal growth factor receptor (EGFR) biology and Wnt developmental signaling highlight research endeavors of SCBA award winners
por: Jeang, Kuan-Teh
Publicado: (2012)

The Expanding Therapeutic Perspective of CCR5 Blockade
por: Vangelista, Luca, et al.
Publicado: (2018)

Receptor Heteromerization Expands the Repertoire of Cannabinoid Signaling in Rodent Neurons
por: Rozenfeld, Raphael, et al.
Publicado: (2012)

Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade
por: Martin, Janet L., et al.
Publicado: (2017)

COVID19 therapeutics: Expanding the antiviral arsenal
por: Gallagher, Tom
Publicado: (2021)

erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines
por: Knowlden, Janice M, et al.
Publicado: (2011)

IL-6 Blockade as a Therapeutic Approach for Duchenne Muscular Dystrophy
por: Mammen, Andrew L., et al.
Publicado: (2015)

A Modular Receptor Platform To Expand the Sensing Repertoire of Bacteria
por: Chang, Hung-Ju, et al.
Publicado: (2017)

Expanding the Regulatory Repertoire of GEFs
por: Robinson, Richard
Publicado: (2013)

An Expanding Repertoire of Protein Acylations
por: Xu, Yuxuan, et al.
Publicado: (2022)

Nuclear epidermal growth factor receptor as a therapeutic target
por: Atwell, Benjamin, et al.
Publicado: (2023)

AZD3759 inhibits glioma through the blockade of the epidermal growth factor receptor and Janus kinase pathways
por: Yin, Wei, et al.
Publicado: (2021)

The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
por: Avila, Jorge, et al.
Publicado: (2023)

Rad51 in regulating the radiosensitivity of non‐small cell lung cancer with different epidermal growth factor receptor mutation status
por: Zhong, Xing, et al.
Publicado: (2015)

Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitro
por: Xie, Bo, et al.
Publicado: (2018)

Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells
por: Tien, Yun, et al.
Publicado: (2020)

A new analysis approach of epidermal growth factor receptor pathway activation patterns provides insights into cetuximab resistance mechanisms in head and neck cancer
por: von der Heyde, Silvia, et al.
Publicado: (2012)

Cost-effectiveness of Osimertinib in activating epidermal growth factor receptor gene (EGFR)-mutations in first-line for advanced non-small cell lung cancer
por: Giuliani, Jacopo, et al.
Publicado: (2021)

Exosomes expand the sphere of influence of Eph receptors and ephrins
por: Pasquale, Elena B.
Publicado: (2016)

Expanding functional repertoires of fungal peroxisomes: contribution to growth and survival processes
por: Maruyama, Jun-ichi, et al.
Publicado: (2013)

Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitro [Erratum]
Publicado: (2018)

Chimeric Antigen Receptors Expand the Repertoire of Antigenic Macromolecules for Cellular Immunity
por: Keane, John T., et al.
Publicado: (2021)

Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
por: Rogers, Jane E., et al.
Publicado: (2023)

Attenuating DNA damage response and immunosuppression radiosensitizes pancreatic cancer
por: Zhang, Yuqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hheemlgkg25j60ilbgoa5vam8d